AG
ANGO icon

Algert Global’s AngioDynamics ANGO Stock Holding History

Algert Global’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,540
Closed -$199K – 1246
2026
Q1 		$199K Buy
+17,540
New +$190K ﹤0.01% 1080
2025
Q4 		– Sell
-13,620
Closed -$152K – 1133
2025
Q3 		$152K Buy
+13,620
New +$131K ﹤0.01% 1064
2024
Q1 		– Sell
-13,970
Closed -$110K – 1073
2023
Q4 		$110K Sell
13,970
-104,370
-88% -$724K ﹤0.01% 1064
2023
Q3 		$865K Buy
118,340
+66,180
+127% +$551K 0.04% 595
2023
Q2 		$544K Buy
52,160
+15,810
+43% +$152K 0.02% 800
2023
Q1 		$376K Buy
+36,350
New +$465K 0.02% 893
2017
Q3 		– Sell
-94,001
Closed -$1.52M – 301
2017
Q2 		$1.52M Sell
94,001
-50,483
-35% -$798K 0.43% 105
2017
Q1 		$2.51M Buy
144,484
+13,381
+10% +$224K 0.68% 26
2016
Q4 		$2.21M Buy
131,103
+89,216
+213% +$1.49M 0.63% 33
2016
Q3 		$735K Buy
+41,887
New +$679K 0.21% 184

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Algert Global's ANGO Position: Q2 2026 in Review

Algert Global sold out of AngioDynamics (ANGO) in Q2 2026, closing a stake of 17,540 shares — an estimated $199K sold.

Algert Global first reported a position in ANGO in Q3 2016 and held it in 10 quarters. The position peaked at $2.51M in Q1 2017. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Algert Global reported no remaining AngioDynamics position as of Q2 2026 after selling out during the quarter.
  • Algert Global sold 17,540 AngioDynamics shares in Q2 2026, an estimated $199K.
  • Algert Global first reported a position in AngioDynamics in Q3 2016 and held it in 10 quarters.
  • Algert Global's AngioDynamics position peaked at $2.51M in Q1 2017.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.